Figure S9. Reprogramming efficiency after GSK3β inhibitor treatment in early stage (days 1–3). Relative levels of alkaline phosphatase (AP)-positive colonies with or without GSK3β inhibitor (CHIR99021, 3 μM) after reprogramming. Data are presented as the mean ± SEM (n = 3). ***P < 0.005 (Student’s t test). (TIF 75 kb